Trichostatin A enhances proliferation and migration of vascular smooth muscle cells by downregulating thioredoxin 1

Cardiovascular Research

Volumn 85, Issue 1, 2010, Pages 241-249

  Song, Seungjeong ^a   Kang, Sang Won ^b   Choi, Chulhee ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Histone deacetylases; Migration; Proliferation; Thioredoxin; Vascular smooth muscle cells

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; THIOREDOXIN 1; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY INJURY; CAROTID ARTERY LIGATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RESTENOSIS; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADPH OXIDASE; PEROXIREDOXINS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; THIOREDOXINS;

EID: 72049083765     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp263     Document Type: Article

References (31)

1. Finkel T. Redox-dependent signal transduction. FEBS Lett 2000;476:52-54.
2. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA et al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci USA 2002; 99:11700-11705.
3. Marks PA, Jiang X. Histone deacetylase inhibitors in programmed cell death and cancer therapy. Cell Cycle 2005;4:549-551.
4. Ruefli AA, Bernhard D, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. Suber-oylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells. Int J Cancer 2002;99:292-298.
5. Martirosyan A, Leonard S, Shi X, Griffith B, Gannett P, Strobl J. Actions of a histone deacetylase inhibitor NSC3852 (5-nitroso-8-quinolinol) link reactive oxygen species to cell differentiation and apoptosis in MCF-7 human mammary tumor cells. J Pharmacol Exp Ther 2006;317:546-552.
6. Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S et al. Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer 2003;103: 572-576.
7. Marks PA. Thioredoxin in cancer-role of histone deacetylase inhibitors. Semin Cancer Biol 2006;16:436-443.
8. Yoshida T, Nakamura H, Masutani H, Yodoi J. The involvement of thioredoxin and thioredoxin binding protein-2 on cellular proliferation and aging process. Ann NY Acad Sci 2005;1055:1-12.
9. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J et al. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 1996;178:179-185.
10. Andres V, Castro C. Antiproliferative strategies for the treatment of vascular pro-liferative disease. Curr Vasc Pharmacol 2003;1:85-98.
11. Park J, Choi K, Jeong E, Kwon D, Benveniste EN, Choi C. Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 2004;47:9-20.
12. Korshunov VA, Berk BC. Strain-dependent vascular remodeling: the 'Glagov phenomenon' is genetically determined. Circulation 2004;110:220-226.
13. Ungerstedt JS, Sowa Y, Xu WS, Shao Y, Dokmanovic M, Perez G et al. Role of thioredoxin in the response of normal and transformed cells to histone deacety-lase inhibitors. Proc Natl Acad Sci USA 2005;102:673-678.
14. Lyle AN, Griendling KK. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 2006;21:269-280.
15. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005;435: 347-353.
16. Choi JH, Nam KH, Kim J, Baek MW, Park JE, Park HY et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2404-2409.
17. Davidson SM, Townsend PA, Carroll C, Yurek-George A, Balasubramanyam K, Kundu TK et al. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. Chembiochem 2005;6: 162-170.
18. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003;112:1395-1406.
19. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. Embo J 2003;22: 5501-5510.
20. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596-2606.
21. Nakamura H, Tamura S, Watanabe I, Iwasaki T, Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 2002;82:165-170.
22. Rosato RR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/ WAF1 1. Cancer Res 2003;63:3637-3645.
23. Takada Y, Gillenwater A, Ichikawa H, Aggarwal BB. Suberoylanilide hydroxamic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing nuclear factor-kappaB activation. J Biol Chem 2006;281:5612-5622. (Pubitemid 43847658)
24. Nishida M, Maruyama Y, Tanaka R, Kontani K, Nagao T, Kurose H. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species. Nature 2000;408: 492-495.
25. Sandirasegarane L, Kester M. Enhanced stimulation of Akt-3/protein kinase B-gamma in human aortic smooth muscle cells. Biochem Biophys Res Commun 2001;283:158-163.
26. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005;6:587-592.
27. Kang SW, Chang TS, Lee TH, Kim ES, Yu DY, Rhee SG. Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha. J Biol Chem 2004;279:2535-2543.
28. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004;109:227-233.
29. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epige-netic (and more) treatments for cancer. Nat Rev Cancer 2006;6:38-51.
30. Choi K, Lee J, Choi C. Divergent effect of proteasome inhibition on interleukin-1 beta and tumor necrosis factor alpha signaling in human astroglial cells. FEBS Lett 2007;581:4691-4696.
31. Zhang J, Velsor LW, Patel JM, Postlethwait EM, Block ER. Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-kappaB. Am J Physiol 1999;277:L787-L793.